Guangdong Hengshu No. 1 Investment Partnership Enterprise (Limited Partnership) signed an agreement to acquire a 9.98% stake in Xiangxue Pharmaceutical Co.,Ltd. (SZSE:300147) from Guangzhou Kunlun Investment Co., Ltd. for approximately CNY 390 million on March 9, 2021. Under the term, Guangdong Hengshu No. 1 Investment Partnership Enterprise acquire 66 million shares of Xiangxue Pharmaceutical at CNY 5.98 per share. Initial payment of CNY 21,78 million within five working days. The first instalment of the share transfer in the account is transferred to the pledgee China Construction Bank Corporation (SEHK: 939) Guangzhou Economic and Technological Development Zone Sub-branch for Guangzhou Kunlun Investment to repay the debts guaranteed by the original share pledge, and at the same time pay the remaining amount of CNY 176.8 million for the share transfer. Post completion, Guangzhou Kunlun Investment Co., Ltd. will hold 21.1815% stake in Xiangxue Pharmaceutical.